美股市場個股詳情

NXPI 恩智浦

添加自選
  • 242.700
  • +4.620+1.94%
收盤價 04/26 16:00 (美東)
  • 242.700
  • 0.0000.00%
盤後 19:11 (美東)
621.54億總市值22.68市盈率TTM
全部分時
  • 5日
  • 日K
  • 周K
  • 月K
  • 季K
  • 年K

資金分布

單位: --

資金流向

實時

暫無數據

評論

    $恩智浦(NXPI.US)$ wow. heavy hitters are buying this up
    $恩智浦(NXPI.US)$在2022年3月的分析中因爲淨利潤波動太大估值過高被排除,至今股價提升25%。
    2010年上市的荷蘭公司,全球化市場,當前價格235.32。
    5年來營收前兩年萎縮,2021年大幅增長,近兩年增速逐步放緩,2023年增長0.54%,5年平均增速7.1%,營業利潤2021年大幅增長7.5倍,2022年達到高點,2023年萎縮3.1%,淨利潤2021年大幅增長到19.1億,幾乎達到2018年22.6億的水平,2022年大幅增長到28.3億,2023年小幅萎縮0.4%。2023年利息費用佔營業利潤的8.4%,利息負擔不算重。毛利率近5年從52%提升到56.9%,淨資產收益率2023年達到了34.8%。
    5年來資產負債率從51.8%提高到63.2%。 應收和存貨的比例和增速都正常,商譽及其他無形資產下降到109億,是90億淨資產的1.2倍,長期借款102億,是淨資產的1.1倍,槓桿率很高。
    目前現金42.71億,流動比率1.9,速動比率1.3。
    5年來現金流經營淨額大幅高於投資淨額,產生了較高比例股東盈餘。
    目前市盈率22,股息率1.7%,考慮到近期增...
    已翻譯
    Insiders selling shares may indicate they believe the shares are overpriced. The level of insider ownership shows some alignment between management and smaller shareholders, but it's not high. This, coupled with recent selling activity, makes the company a cautious investment choice.

    專欄Today's Morning Movers and Top Ratings: SPOT, LLY, TSLA, UBS and More

    Morning Movers
    Gapping up
    $Spotify Technology(SPOT.US)$ Shares of Spotify Technology jumped over 3% in premarket trading Tuesday after the company's upbeat Q1 operating income guidance.
    Spotify's Q4 loss per share in the quarter decreased significantly to €0.36 from €1.40 year-over-year. Analysts were looking for a loss per share of €0.37. Revenue reached €3.67 billion in the quarter, marking a 16% increase YoY.
    $恩智浦(NXPI.US)$ Shares of...
    Today's Morning Movers and Top Ratings: SPOT, LLY, TSLA, UBS and More
    3
    Palantir's Q4 commercial business performance was 'bombastic, baller, incomprehensibly good', according to CEO Alex Karp. Coherent sees 'improving demand trends', expecting 'ongoing sequential improvement in revenue growth'. Chegg's Q1 guidance disappointed investors. NXP Semiconductors' Q4 results surpassed expectations. Novartis' acquisition of MorphoSys is viewed positively.
閱讀更多

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅